Search
Amyotrophic Lateral Sclerosis Paid Clinical Trials in New York
A listing of 14 Amyotrophic Lateral Sclerosis clinical trials in New York actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 14 of 14
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Amyotrophic Lateral Sclerosis
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of New York currently has 14 active clinical trials seeking participants for Amyotrophic Lateral Sclerosis research studies. These trials are conducted in various cities, including New York, Rochester, Bronx and Buffalo.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Irritability Associated with Autism (Children and Adolescents) Study
Recruiting
Join a clinical trial today and take a step toward finding a better solution for you. Earn money for your time and no-cost medical treatment is provided.
Featured Trial
KALOS
Recruiting
The KALOS study is evaluating if an investigational inhaler called BGF MDI may provide benefit for people whose asthma symptoms are not fully controlled using their current inhaler treatment.
Exploratory Evaluation of [11C]MPC6827
Recruiting
This is a phase 0 study that will enable an assessment of biodistribution and estimation of absorbed dose in humans based on data collected from five healthy volunteers, which is typically the minimum number required by the FDA for first-in-human studies to assess dosimetry of a new tracer. The evaluation of the brain imaging of thirty additional subjects in the 2nd part of the study will lead to a descriptive assessment of the targeting and pharmacokinetics of MPC6827 in the brain and between n... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/24/2023
Locations: Cuimc / Nyp, New York, New York
Conditions: Neurodegenerative Diseases, Alzheimer Disease, Amyotrophic Lateral Sclerosis
Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)
Recruiting
This study is a multi-center, open-label study of intravenous (IV) ANX005 in participants with ALS.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/23/2023
Locations: Annexon Investigational Site 06, New York, New York
Conditions: Amyotrophic Lateral Sclerosis
13 - 14 of 14